Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Context Investigational Site, Denver, Colorado Context Investigational Site, Chicago, Illinois Context Investigational Site, Grand Rapids, Michigan Context Investigational Site, Hackensack, New Jersey Context Investigational Site, Philadelphia, Pennsylvania Context Investigational Site, Nashville, Tennessee Context Investigational Site, San Antonio, Texas Context Investigational Site, San Antonio, Texas